139 related articles for article (PubMed ID: 2536272)
1. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.
Mahley RW; Hui DY; Innerarity TL; Beisiegel U
Arteriosclerosis; 1989; 9(1 Suppl):I14-8. PubMed ID: 2536272
[TBL] [Abstract][Full Text] [Related]
2. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.
Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK
Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E-binding proteins isolated from dog and human liver.
Beisiegel U; Weber W; Havinga JR; Ihrke G; Hui DY; Wernette-Hammond ME; Turck CW; Innerarity TL; Mahley RW
Arteriosclerosis; 1988; 8(3):288-97. PubMed ID: 2835955
[TBL] [Abstract][Full Text] [Related]
4. Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins.
Elsegood CL; Pal S; Roach PD; Mamo JC
Clin Sci (Lond); 2001 Aug; 101(2):111-9. PubMed ID: 11473484
[TBL] [Abstract][Full Text] [Related]
5. Receptor interactions controlling lipoprotein metabolism.
Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
Can J Biochem Cell Biol; 1985 Aug; 63(8):898-905. PubMed ID: 2998579
[TBL] [Abstract][Full Text] [Related]
6. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
Chait A
Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
[TBL] [Abstract][Full Text] [Related]
7. Interaction of apo E-containing lipoproteins with the LDL-receptor-related protein, LRP.
Harrach-Ruprecht B; Küchenhoff A; Robenek H
Z Gastroenterol; 1996 Jun; 34 Suppl 3():122-3. PubMed ID: 8767486
[TBL] [Abstract][Full Text] [Related]
8. Binding of apolipoprotein E-rich remnant lipoproteins to human liver membranes.
Florén CH
Scand J Gastroenterol; 1984 Jun; 19(4):473-9. PubMed ID: 6463569
[TBL] [Abstract][Full Text] [Related]
9. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
10. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver.
Windler E; Greeve J; Robenek H; Rinninger F; Greten H; Jäckle S
Hepatology; 1996 Aug; 24(2):344-51. PubMed ID: 8690403
[TBL] [Abstract][Full Text] [Related]
11. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
Shimano H; Namba Y; Ohsuga J; Kawamura M; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
J Clin Invest; 1994 May; 93(5):2215-23. PubMed ID: 8182153
[TBL] [Abstract][Full Text] [Related]
12. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein receptors.
Lestavel S; Fruchart JC
Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):461-81. PubMed ID: 8061563
[TBL] [Abstract][Full Text] [Related]
14. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein binding to cultured human hepatoma cells.
Krempler F; Kostner GM; Friedl W; Paulweber B; Bauer H; Sandhofer F
J Clin Invest; 1987 Aug; 80(2):401-8. PubMed ID: 3038957
[TBL] [Abstract][Full Text] [Related]
17. Receptor and non-receptor mediated uptake of chylomicron remnants by the liver.
Havel RJ
Atherosclerosis; 1998 Dec; 141 Suppl 1():S1-7. PubMed ID: 9888635
[TBL] [Abstract][Full Text] [Related]
18. Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.
Mahley RW; Hui DY; Innerarity TL; Weisgraber KH
J Clin Invest; 1981 Nov; 68(5):1197-206. PubMed ID: 6271808
[TBL] [Abstract][Full Text] [Related]
19. [Intestinal apolipoprotein metabolism].
Steinmetz A
Klin Wochenschr; 1990; 68 Suppl 22():12-8. PubMed ID: 2087069
[TBL] [Abstract][Full Text] [Related]
20. The role of lipoprotein lipase and apoprotein E in the recognition of chylomicrons and chylomicron remnants by cultured isolated mouse hepatocytes.
Chang S; Maeda N; Borensztajn J
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):29-34. PubMed ID: 8761448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
